XERIS BIOPHARMA HOLDINGS, INC. Public Float
XERIS BIOPHARMA HOLDINGS, INC. (XERS) had Public Float of $731.10 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $731.10M.
- 2024-06-30: Entity Public Float $335.10M.
- 2023-06-30: Entity Public Float $361.60M.
- 2022-06-30: Entity Public Float $209.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $731.10M 10-K · filed 2026-03-02 |
| 2024-06-30 | $335.10M 10-K · filed 2025-03-06 |
| 2023-06-30 | $361.60M 10-K · filed 2024-03-06 |
| 2022-06-30 | $209.30M 10-K · filed 2023-03-08 |
| 2021-06-30 | $266.00M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |